SCHEMBL765223

SCHEMBL765223

CCC1CCC=CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17675587 0.82
SCHEMBL16404862 0.82
SCHEMBL8515614 0.77 SMN1; SMN2 (0.33)
SCHEMBL19210127 0.77
SCHEMBL8705311 0.76
SCHEMBL186805 0.76
SCHEMBL19128726 0.76
SCHEMBL3637989 0.76
SCHEMBL12850800 0.76
SCHEMBL260769 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12202826-B2 N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway REDX PHARMA PLC (GB) 2025-01-21 US disclosed
US-20230365549-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY REDX PHARMA PLC (GB) 2023-11-16 US disclosed
US-11673907-B2 Modular synthesis of aminoglycosides REVAGENIX, INC. (US) 2023-06-13 US disclosed
US-11643408-B2 N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway REDX PHARMA PLC (GB) 2023-05-09 US disclosed
US-20230121489-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS WNT SIGNALLING PATHWAY INHIBITORS REDX PHARMA PLC (GB) 2023-04-20 US disclosed
EP-4071150-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS WNT SIGNALLING PATHWAY INHIBITORS Redx Pharma Plc (GB) 2022-10-12 EP disclosed
US-11459326-B2 N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors REDX PHARMA PLC (GB) 2022-10-04 US disclosed
EP-3204378-B3 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY REDX PHARMA PLC (GB) 2022-05-25 EP disclosed
US-20210046076-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY REDX PHARMA PLC (GB) 2021-02-18 US disclosed
US-20200407356-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS WNT SIGNALLING PATHWAY INHIBITORS REDX PHARMA PLC (GB) 2020-12-31 US disclosed
WO-2008075172-A2 NICOTINAMIDE DERIVATIVES AS INHIBITORS OF H-PGDS AND THEIR USE FOR TREATING PROSTAGLANDIN D2 MEDIATED DISEASES PFIZER PRODUCTS INC. (US) 2008-06-26 WO disclosed
EP-1812542-A1 FRAGRANCE COMBINATION COMPRISING 3,7-DIMETHYLOCT-6-ENE NITRILE (CITRONELLYL NITRILE) AS GERANONITRILE SUBSTITUTE HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-08-01 EP disclosed
EP-1472232-B1 PROCESSES FOR PREPARING IMIDAZOLE DERIVATIVES AND SALTS THEREOF YUHAN CORP (KR) 2007-01-24 EP disclosed
WO-2006053615-A1 FRAGRANCE COMBINATION COMPRISING 3,7-DIMETHYLOCT-6-ENE NITRILE (CITRONELLYL NITRILE) AS GERANONITRILE SUBSTITUTE HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-05-26 WO disclosed
EP-1472232-A4 PROCESSES FOR PREPARING IMIDAZOLE DERIVATIVES AND SALTS THEREOF YUHAN CORP (KR) 2006-02-01 EP disclosed
EP-1472232-A1 PROCESSES FOR PREPARING IMIDAZOLE DERIVATIVES AND SALTS THEREOF Yuhan Corporation (KR) 2004-11-03 EP disclosed
US-6706888-B2 REACTING A 3-HALOTETRAHYDROFURAN OR TETRAHYDROPYRAN COMPOUND WITH FORMAMIDINE OR ITS SALT IN THE PRESENCE OF A BASE TO PRODUCE A 3-(1H-IMIDAZOL-4-YL)PROPANOL DERIVATIVE; EFFICIENCY; INTERMEDIATES; ANTICARCINOGENIC AGENTS; VIRICIDES; YUHAN CORPORATION (KR) 2004-03-16 US disclosed
US-20030153769-A1 Processes for preparing imidazole derivatives and salts thereof YUHAN CORPORATION 2003-08-14 US disclosed
WO-2003066600-A1 PROCESSES FOR PREPARING IMIDAZOLE DERIVATIVES AND SALTS THEREOF YUHAN CORPORATION (KR) 2003-08-14 WO disclosed
US-4125542-A INSECTICIDE VELSICOL CHEMICAL CORPORATION (US) 1978-11-14 US disclosed